If you made any changes in Pure these will be visible here soon.

Research Output 2019 2019

2019

Clinical Outcomes of Lu-177-PSMA Radioligand Therapy in Earlier and Later Phases of Metastatic Castration-Resistant Prostate Cancer Grouped by Previous Taxane Chemotherapy

Barber, T. W., Singh, A., Kulkarni, H. R., Niepsch, K., Billah, B. & Baum, R. P., 1 Jul 2019, In : Journal of Nuclear Medicine. 60, 7, p. 955-962 8 p.

Research output: Contribution to journalArticleAcademicpeer-review

Lu-177-PSMA-617 Radioligand Therapy in Metastatic Castration-Resistant Prostate Cancer Patients with a Single Functioning Kidney

Zhang, J., Kulkarni, H. R., Singh, A., Schuchardt, C., Niepsch, K., Langbein, T. & Baum, R. P., 1 Nov 2019, In : Journal of Nuclear Medicine. 60, 11, p. 1579-1586 8 p.

Research output: Contribution to journalArticleAcademicpeer-review

Parameters to Predict Progression-Free and Overall Survival After Peptide Receptor Radionuclide Therapy: A Multivariate Analysis in 782 Patients

Aalbersberg, E. A., Huizing, D. M. V., Walraven, I., de Wit-van der Veen, B. J., Kulkarni, H. R., Singh, A., Stokkel, M. P. M. & Baum, R. P., 1 Sep 2019, In : Journal of Nuclear Medicine. 60, 9, p. 1259-1265 7 p.

Research output: Contribution to journalArticleAcademicpeer-review

Preclinical investigations and first-in-human application of Tb-152-PSMA-617 for PET/CT imaging of prostate cancer

Mueller, C., Singh, A., Umbricht, C. A., Kulkarni, H. R., Johnston, K., Bensova, M., Senftleben, S., Mueller, D., Vermeulen, C., Schibli, R., Koester, U., van der Meulen, N. P. & Baum, R. P., 25 Jul 2019, In : EJNMMI Research. 9, 10 p., 68.

Research output: Contribution to journalArticleAcademicpeer-review

Open Access